As we enter 2026, the global biopharmaceutical sector is navigating a period of "purposeful transformation." The Cytokines Market Economic Outlook for this year reflects a resilient global economy, with the industry benefiting from front-loaded fiscal stimulus and a cautious but steady recovery in biotech funding. While inflationary pressures remain "sticky" at around 3%, the demand for...